Re: Gene expression-based prognostic signatures in lung cancer: Ready for clinical use?

Journal of the National Cancer Institute

Volumn 102, Issue 21, 2010, Pages 1677-1678

  Boutros, Paul C ^a   Pintilie, Melania ^c   John, Thomas ^c   Starmans, Maud H W ^a,b   Der, Sandy D ^c   Shepherd, Frances A ^c   Tsao, Ming Sound ^c   Jurisica, Igor ^c  

^a ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

CANCER RISK; CANCER STAGING; CLINICAL ASSESSMENT; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROGNOSIS; PUBLISHING; RISK FACTOR; SAMPLE SIZE; SCORING SYSTEM; VALIDATION PROCESS;

CARCINOMA, NON-SMALL-CELL LUNG; DATA INTERPRETATION, STATISTICAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RESEARCH DESIGN; TUMOR MARKERS, BIOLOGICAL;

EID: 78149308719     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq385     Document Type: Letter

References (7)

1. Subramanian J, Simon R. Gene expression-based prognostic signatures in lung cancer: ready for clinical use? J Natl Cancer Inst. 2010; 102 (7): 464-474.
2. Boutros PC, Lau SK, Pintilie M, et al. Prognostic gene signatures for non-small-cell lung cancer. Proc Natl Acad Sci \USA. 2009; 106 (8): 2824-2828.
3. Lau SK, Boutros PC, Pintilie M, et al. Three-gene prognostic classifi er for early-stage non small-cell lung cancer. J Clin Oncol. 2007; 25 (35): 5562-5569.
4. Shedden K, Taylor JM, Enkemann SA, et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med. 2008; 14 (8): 822-827.
5. Kyzas PA, Denaxa-Kyza D, Ioannidis JP. Almost all articles on cancer prognostic markers report statistically signifi cant results. Eur J Cancer. 2007; 43 (17): 2559-2579.
6. Roepman P, Jassem J, Smit EF, et al. An immune response enriched 72-gene prognostic profi le for early-stage non-small-cell lung cancer. Clin Cancer Res. 2009; 15 (1): 284-290.
7. Butts CA, Ding K, Seymour L, et al. Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10. J Clin Oncol. 2010; 28 (1): 29-34.